4//SEC Filing
Wise John Drayton 4
Accession 0001628280-24-023613
CIK 0001104506other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:39 PM ET
Size
9.5 KB
Accession
0001628280-24-023613
Insider Transaction Report
Form 4
INSMED IncINSM
Wise John Drayton
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-05-13+14,518→ 128,347 total - Sale
Common Stock
2024-05-14$25.47/sh−5,088$129,591→ 123,259 total - Award
Stock Option (right to buy)
2024-05-13+71,160→ 71,160 totalExercise: $25.83Exp: 2034-05-13→ Common Stock (71,160 underlying)
Footnotes (5)
- [F1]Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
- [F2]Each RSU was granted on May 13, 2024 for no consideration.
- [F3]Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.
- [F4]This is the weighted average sales price representing 5,088 shares sold at prices ranging from $25.45 to $25.50 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- [F5]These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date.
Documents
Issuer
INSMED Inc
CIK 0001104506
Entity typeother
Related Parties
1- filerCIK 0001930805
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:39 PM ET
- Size
- 9.5 KB